• Systematic Review Of Markov Model-Based Economic Evaluation Studies For Cervical Cancer Screening Strategies- Latin America Countries Panorama

    Oct 1, 2017, 00:00

  • Adherence to Oral Antidiabetic Medication in Type 2 Diabetes Mellitus Clients in the Volta Region of Ghana

    Oct 1, 2017, 00:00

  • Inpatient Medication Errors And Pharmacist Intervention At Ministry Of Health Public Hospital In Riyadh, Saudi Arabia

    Oct 1, 2017, 00:00

  • Treatment Patterns And Resource Use Of Type 2 Diabetes Patients Managed On Insulin In England – Results Of A Delphi Panel

    Oct 1, 2017, 00:00

  • Description Of The Chinese Health Care System After The Health Care Reform

    Oct 1, 2017, 00:00

  • Psychosocial Determinants of Depressive Illness Among Women Attending in Psychiatric Out Patients Department of Bangabandhu Sheikh Mujib Medical University(BSMMU) Dhaka, Bangladesh

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Apremilast for the Treatment of Active Psoriatic Arthritis In Greece

    Oct 1, 2017, 00:00

  • Budget Impact Model of Point of Care Test for Patients Under Chronic Warfarin Therapy in Brazil

    Oct 1, 2017, 00:00

  • A Qualitative Interview Study to Explore the Patient Experience of Locally Advanced or Metastatic Pancreatic Cancer and Explore the Content of Patient-Reported Outcome Measures

    Oct 1, 2017, 00:00

  • Evaluating The Conceptual Equivalence Between Paper And Three Electronic Data Collection Modes Of The EQ-5D-5L Health Status Instrument

    Oct 1, 2017, 00:00

  • Innovative Pricing and Reimbursement Schemes – The What, Why, Which, and How

    Oct 1, 2017, 00:00

  • Bridging The Gap Between International Standards Of Quality Of Care And Practices In The Inpatient Unit Of The National TB Control Center In Armenia

    Oct 1, 2017, 00:00

  • Budget-Impact of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Greece

    Oct 1, 2017, 00:00

  • Hemodynamic Monitoring Can Reduce Costs on High Risk Patients WHO Underwent Large/Medium Surgical Procedures

    Oct 1, 2017, 00:00

  • The Cost-Effectivness Analysis of The Latent Tuberculosis Infection Screening For Adults 40 Years old In South Korea

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Modelling in The Early Health Technology Assessment of Generic Pegylated Liposomal Doxorubicin

    Oct 1, 2017, 00:00

  • A Literature Analysis Of Cost Studies On Cancer

    Oct 1, 2017, 00:00

  • Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • A Typology-Based Decisional Framework To Support Market Access And Reimbursement Decisions For Personalised Medicines

    Oct 1, 2017, 00:00

  • Evaluation Of Baranya County Drug Ambulance's And Baranya County Police's School Based Drug Prevention Activity

    Oct 1, 2017, 00:00

  • Critical Assessment Of Atmp Market Access Outcomes On A National-Level Across EU5 Countries

    Oct 1, 2017, 00:00

  • Burden of Renal Transplant Among A Cohort of US Medicare Beneficiaries With Autosomal Dominant Polycystic Kidney Disease

    Oct 1, 2017, 00:00

  • A Snapshot of Medication Adherence Across Three European Countries- Application of Common Methodology

    Oct 1, 2017, 00:00

  • Access To Psoriasis Drug Treatment Among Brazilian Patients

    Oct 1, 2017, 00:00

  • A Claims Data Analysis of Biological Agents for Psoriatic Arthritis In Germany

    Oct 1, 2017, 00:00

  • Accessibility To Oncologic Treatment In Sus Public Health Systems And Obamacare

    Oct 1, 2017, 00:00

  • Cost-Consequences Of Using Fluciclovine (F 18) For The Diagnosis And Staging Of Recurring Prostate Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Roflumilast As Add-On To Triple Inhaled Therapy Versus Triple Inhaled Therapy In Patients With Severe And Very Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis In The Netherlands

    Oct 1, 2017, 00:00

  • Assessing The Healthcare Cost of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for The Treatment of Heart Failure In Argentina

    Oct 1, 2017, 00:00

  • Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy- A Meta-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials

    Oct 1, 2017, 00:00

  • Group Concept Mapping As A Strategy for Defining Patient-Centered Outcomes In Proms and Pro-Pms

    Oct 1, 2017, 00:00

  • Withdrawn

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Brazil

    Oct 1, 2017, 00:00

  • Costo-Utilidad De La Vacunación Contra Varicela En Perú

    Oct 1, 2017, 00:00

  • Identifying a Claims-Based Definition of Satisfaction with Linaclotide Treatment Among Patients with Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC)

    Oct 1, 2017, 00:00

  • UK Utility Elicitation in Patients with Follicular Lymphoma

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece

    Oct 1, 2017, 00:00

  • Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US

    Oct 1, 2017, 00:00

  • The Financial Burden of Diabetes Mellitus Type 1 And Type 2 In Egypt

    Oct 1, 2017, 00:00

  • Impact Of A Pharmacist-Led Intervention On The Knowledge Of Appropriate Use Of Peak Flow Meter And Asthma Action Plan Among Pharmacy Students- A Simulated Patient Approach

    Oct 1, 2017, 00:00

  • Treatment Pattern Of Patients Diagnosed With Prostate Cancer In Korea- A Trend Analysis Using Nationwide Health Insurance Database

    Oct 1, 2017, 00:00

  • Real-World Cost Effectiveness Comparison Of Symbicort Turbuhaler And Duoresp Spiromax In UK Patients With Asthma Or Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Costo Y Consumo De Recursos De Pacientes Posterior A Enfermedad Cerebrovascular En Colombia

    Oct 1, 2017, 00:00

  • Correlation Analysis Between Health State Values Derived From EQ-5D-5L And EQ-VAS in Japanese Breast Cancer Patients

    Oct 1, 2017, 00:00

  • The Study on Mechanism of Nf-Κb Signal Molecule In Kashin-Beck Disease

    Oct 1, 2017, 00:00

  • Migraine Burden and Costs- A Nationwide Population-Based Controled Cohort Study Using The French EGB Database

    Oct 1, 2017, 00:00

  • Application Of Multi-Criteria Decision Analysis (MCDA) To Determine The Value Of Treatments For The Moderate To Severe Plaque Psoriasis In Spain

    Oct 1, 2017, 00:00

  • A Review Of Methods For Item Selection In The Development Of A Descriptive System For Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • Estimating The Cost of Diabetes-Related Cardiovascular Complications In Selected Central And Eastern European Countries

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Fingolimod for The Treatment Multiple Sclerosis In Korea

    Oct 1, 2017, 00:00

  • Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany- A Real-World Preliminary Analysis

    Oct 1, 2017, 00:00

  • Determination Of Needs And Priorities In Order To Better Organization Of Antenatal Courses

    Oct 1, 2017, 00:00

  • E-Health Funding In Europe

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • Is the Disconnect Between European Member State Controlled Compassionate Use Programs and the Centralised EMA Process Creating an Early Access Lottery for Patients?

    Oct 1, 2017, 00:00

  • Suspected Adverse Reactions (SARS) To Systemic Glucocorticoid Usage In Dogs In Primary Veterinary Practice In The UK

    Oct 1, 2017, 00:00

  • Toric Intraocular Lenses for the Correction of Pre-Existing Corneal Astigmatism During Cataract Surgery- A Systematic Review of the Literature

    Oct 1, 2017, 00:00

  • How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Systematic Review of Cohort-Level Economic Models for Antipsychotics In Schizophrenia

    Oct 1, 2017, 00:00

  • Spirometry Comparison Of Lung Fuction Between Coalminers And Non-Coalminers

    Oct 1, 2017, 00:00

  • The Development And Use Of A Preliminary Conceptual Model Of Inflammatory Bowel Disease (IBD) To Facilitate Patient Reported Outcome (PRO) Instrument Selection For A UK Real-World Evidence Study

    Oct 1, 2017, 00:00

  • Population Health Impact of Omalizumab over 15 Years of Experience in Moderate to Severe Allergic Asthma

    Oct 1, 2017, 00:00

  • Assessment of Nurse's Knowledge, Attitude and Practice Regarding Hepatitis-B Infection in Tertiary Care Public Hospital in Quetta Pakistan

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis of Dutasteride Plus Tamsulosin Combination Therapy Versus Tamsulosin Monotherapy in The Treatment of Benign Prostatic Hyperplasia in Iran

    Oct 1, 2017, 00:00

  • Factors Related To Outpatient Antibiotic Drug Consumption In Turkey

    Oct 1, 2017, 00:00

  • Quality of Life Assessment in Ild – A Comparison of EQ-5D with The Disease-Specific K-Bild

    Oct 1, 2017, 00:00

  • Modelización Económica Del Ajuste Por Riesgo Del Gasto Sanitario Per Cápita Segun Morbilidad En La Comunidad Valenciana, España

    Oct 1, 2017, 00:00

  • Alternative Reimbursement Models for High Cost Health Technologies

    Oct 1, 2017, 00:00

  • Factors Associated with Multi-Drug Resistant Tuberculosis Incidence In Ghana- A 1-2 Unmatched Case Control Study, 2017

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin In Patients With Type 2 Diabetes Mellitus At High Cardiovascular Risk In Poland

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Long-Acting Parenteral Antipsychotic Drug Flufenazine In The Treatment of Schizophrenia In Russia- A Hospital Perspective

    Oct 1, 2017, 00:00

  • Cognitive assessments on portable devices- A comparison between phones and tablets

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact At Health Related Quality Of Life At Patients Diagnosed With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Análise De Custo-Efetividade Do Tratamento Diretamente Observado Da Tuberculose

    Oct 1, 2017, 00:00

  • Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany

    Oct 1, 2017, 00:00

  • Real-World Management And Outcomes Of Patients With Multiple Myeloma In Romania And Poland

    Oct 1, 2017, 00:00

  • Medical Transportation Costs In Fran Which Source To Estimate Them In Health-Economic Analysis?

    Oct 1, 2017, 00:00

  • Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia

    Oct 1, 2017, 00:00

  • Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil

    Oct 1, 2017, 00:00

  • Posterior Capsule Opacification After Cataract Extraction And Related Healthcare Costs In Germany – A Claims Data Analysis On The Impact Of The Implanted Type Of Intraocular Lenses

    Oct 1, 2017, 00:00

  • Estimation of the Budget Saving Potential Due to the Introduction of an Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Portugal

    Oct 1, 2017, 00:00

  • Identifying Evidence on The Cost-Effectiveness of Treatments And Costs/Resource Use And Quality of Life of Patients with Follicular Lymphoma And Marginal Zone Lymphoma- Systematic Reviews

    Oct 1, 2017, 00:00

  • Clinical Trial Simulations Based on A Meta-Analysis of Studies In Patients With Locally Advanced and/or Metastatic Adenocarcinoma Pancreatic Cancer Receiving Gemcitabine (GEM) Alone or In Combination

    Oct 1, 2017, 00:00

  • The Impress Of Pharmacoeconomics In Pricing Decisions In IFDA

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Treatment Comparison of The Efficacy of Semaglutide Versus Empagliflozin As Add-on To Basal Insulin

    Oct 1, 2017, 00:00

  • Growth of National Health Insurance Expenditure Related To Antidiabetics And Their Projections Up Until 2020

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Costs Associated With Transthyretin Familial Amyloid Polyneuropathy Progression

    Oct 1, 2017, 00:00

  • A Study on Evaluation of Fall Risk Among Geriatric Patients At A Tertiary Care Public Teaching Hospital

    Oct 1, 2017, 00:00

  • Antibiotics Treatment Patterns As A Costs And Resource Utilization Predictor Among Patients Submitted To Bariatric Surgery- Analysis of A Large Health Insurance Claims Database

    Oct 1, 2017, 00:00

  • Prevalence of and Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes Mellitus in Primary Healthcare Centers in Qatar- A Quantitative Analysis

    Oct 1, 2017, 00:00

  • Comparing Surgical Therapy and Hormonal Therapy In Incidence Of Cardiovascular Disease Among Prostate Cancer Patients In Korea

    Oct 1, 2017, 00:00

  • Preferences of The General Population To Avoid Oral Health Outcomes- Results of A Bayesian Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Epidemiological Estimates and Treatment Practice Pattern in Polycythemia Vera Patients in Turkey- Results Based on an Expert Panel

    Oct 1, 2017, 00:00

  • GDP And Population Size – Important Determinants of Schizophrenia-Related Healthcare Costs In The European Countries

    Oct 1, 2017, 00:00

  • Health Loss Due To Market Access Delays And Reimbursement Restrictions In First-Line EGFR-Positive Non-Small Cell Lung Cancer In The EU5 Countries

    Oct 1, 2017, 00:00

  • Economic Impact Of Moderate And Severe Neurotrophic Keratitis In Italy

    Oct 1, 2017, 00:00

  • Impact Of Using Overall Survival Or Progression-Free Survival In Outcomes-Based Pricing Arrangements

    Oct 1, 2017, 00:00

  • A Discrete Choice Experiment To Elicit Diabetes Treatment Preferences Among Adolescents With Type 1 In Western Australia

    Oct 1, 2017, 00:00

  • Myocardial Revascularization- Comparative Cost Study In South America Health Care System

    Oct 1, 2017, 00:00

  • Impact of Drug Related Problems on Blood Pressure Control In Patients With Hypertension In Indonesian Primary Health Care

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Fulvestrant 500 Mg in Endocrine Therapy-Naïve Women with Hormone Receptor-Positive Advanced Breast Cancer in The UK

    Oct 1, 2017, 00:00

  • Health Related Quality of Life in Cancer Immunotherapy- Previously Treated, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Trastuzumab As A Therapy Versus Other Treatment Regimens In Patients With HER2 Positive Breast Cancer- A Systematic Review of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Financial Optimization in The Treatment for Rheumathoid Artritis in Patients Receiving Conventional Dmard Therapy

    Oct 1, 2017, 00:00

  • Could Embase Emtree Index Search Terms Be Focused To Reduce Numbers To Screen In Clinical Systematic Reviews?

    Oct 1, 2017, 00:00

  • Quality Of Reporting And Analysis Of Trial-Based Cost Efectiveness Evaluations In Obstetrics And Gynaecology; A Systematic Review

    Oct 1, 2017, 00:00

  • Effects of Propofol Versus Other General Anesthesia in Children Younger Than 3 Years of Age- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Disease-Specific Patient-Reported Outcome Instruments In Sickle Cell Disease- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Diabetes Mellitus In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Paying For Gene Therapies- Approaching A Sustainable Solution

    Oct 1, 2017, 00:00

  • A Systematic Review of Pharmacoeconomic Evaluation of Erlotinib in The First-Line Treatment of Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Sink or Swim- How Can Asthma Biologics Successfully Sail the Rough Waters of EU5 Market Access?

    Oct 1, 2017, 00:00

  • The Coordinated Management Of Patient With Mental Illness In Spain By Hospital, Primary Care And Community Pharmacists (3PH), A Resource Optimization Model

    Oct 1, 2017, 00:00

  • Biosimilar Discounts are Not Similar- A Comparison of The Prices and Discounts of Anti-Tnf Biosimilars Between Canada and Europe

    Oct 1, 2017, 00:00

  • Involvement Of Community Pharmacists In Public Health Priorities- A Multi-Center Descriptive Survey In Ethiopia

    Oct 1, 2017, 00:00

  • Developing a Multi-Criteria Framework for Innovation and Biologic Drugs Assessment Decision Making in Egypt

    Oct 1, 2017, 00:00

  • Personalised Health Definitions – A New Supplemental Framework to Interpret Individuals’ Responses on the EQ-5D-VAS

    Oct 1, 2017, 00:00

  • The Importance of Perspective When Evaluating The Economic Value of Vocational Rehabilitation

    Oct 1, 2017, 00:00

  • Multiplatform Tumor Profiling Delivers Value Based Health Care In Refractory Cancer Patients

    Oct 1, 2017, 00:00

  • Assessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo- Preliminary Data

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Insulin Pumps Versus Multiple Daily Insulin (MDI) Injection In Type 1 Diabetes In India From Societal Perspective

    Oct 1, 2017, 00:00

  • Work Productivity And Impairment Among Patients With Light Chain Amyloidosis

    Oct 1, 2017, 00:00

  • Metanálise De Segurança Do Tratamento Medicamentoso De Pacientes Com Transtorno Do Déficit Da Atenção com Hiperatividade E Ansiedade

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns And Time To Discontinuation In Rheumatoid Arthritis Patients In The US

    Oct 1, 2017, 00:00

  • Implementation Of A Data Mining Model Within A Monitoring Web-Based Tool To Assess HER2 Breast Cancer Status Using The Her-France Real World Database

    Oct 1, 2017, 00:00

  • The Global Burden Of Gastric (GC) And Gastroesophageal Junction (GEJC) Cancers

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Colombia

    Oct 1, 2017, 00:00

  • An Accessible Comparison Of Traditional Statistical And Machine Learning Approaches To Analysis Of Real World Data- Which, When And Why?

    Oct 1, 2017, 00:00

  • Health Technologies' Taxonomy and Challenges To Apply The Assessment

    Oct 1, 2017, 00:00

  • Indicative Budget Impact Of Posaconazole Versus Fluconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With AML/MDS

    Oct 1, 2017, 00:00

  • Long-Term work Productivity improvement from Phase 3 Baricitinib Ra-Beam Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Prevalence of Anticonvulsants Utilization at a Tertiary Hospital in Southeast Nigeria; Bridging the Gaps Between Facilities Outcomes and Policies Through Evidence-Based Reports

    Oct 1, 2017, 00:00

  • Feasibility Assessment- The Impact of A Reduced Operating Room Footprint System On The Resources Required For Instrument Management In Deformity Surgery From An Italian Hospital Perspective

    Oct 1, 2017, 00:00

  • Micro Economic Analysis Of The COPD Exacerbations And Hospitalizations Burden On The Health Care System In Bulgaria

    Oct 1, 2017, 00:00

  • Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists

    Oct 1, 2017, 00:00

  • Access Perceptions- A Key Driver Of Non-Small Cell Lung Cancer (NSCLC) Targeted Therapy Prescription In Russia

    Oct 1, 2017, 00:00

  • Consulta Pública Como Instrumento De Diálogo E Negociação Entre Indústria E Governo

    Oct 1, 2017, 00:00

  • Accelerated Uptake Of Innovative Health Technologies- A Literature Review

    Oct 1, 2017, 00:00

  • The Role of Community Pharmacists in Patient Counselling and Health Education- A Survey of Their Knowledge and Level of Involvement in Relation to Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Cost Associated with Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement in Latin America

    Oct 1, 2017, 00:00

  • Indirect Comparisions Presented In German Benefit Assessments – Status Quo and Quo Vadis?

    Oct 1, 2017, 00:00

  • Cost –Utility Analysis of Two Budesonide Inhalers For Treatment of Asthma In Children In Russian Federation

    Oct 1, 2017, 00:00

  • Budget Impact of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients

    Oct 1, 2017, 00:00

  • Time to Access- Too Fast, Too Slow, or Just Right? An Evolving Public Reimbursement Landscape of Drugs For Rare Diseases In Canada

    Oct 1, 2017, 00:00

  • The Comparative Pharmacoeconomic Analysis Of Using Absorb Bioresorbable Vascular Scaffold System For Patients With St Segment Elevation Myocardial Infarction (STEMI)

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Liver Transplantation Compared To Chemotherapy for Non-Resectable Liver-Only Metastases After Colorectal Cancer (MCRC)

    Oct 1, 2017, 00:00

  • How Will Proposed Changes To The Nice Highly Specialised Technology Evaluation Process Impact Patient Access To Innovative Drugs for Rare Diseases?

    Oct 1, 2017, 00:00

  • Medication Adherence and Quality of Life of Uncontrolled Hypertension Patients in Korea

    Oct 1, 2017, 00:00

  • Evaluation of Safety and Efficacy of Propofol for Procedural Sedation in Pediatric Population- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Pattern Of Anti-Infective Drugs Use In A Tertiary Healthcare Facility In Nigeria

    Oct 1, 2017, 00:00

  • An Exploration of the Methodology of Published Systematic Literature Reviews on “Burden of Disease”

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Tocilizumab, Infliximab and Etanercept Drugs for The Treatment of Rheumatoid Arthritis in Ecuador

    Oct 1, 2017, 00:00

  • Potential Medication Triggers Of Deteriorated Renal Function Among Patients With Type 2 Diabetes- Using Real World Data

    Oct 1, 2017, 00:00

  • Assessment Of Knowledge And Perceived Practices Of Antimicrobial Stewardship Among Malaysian Future Healthcare Professionals

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Ivabradine In The Treatment Of Chronic Heart Failure From The Mexican Perspective

    Oct 1, 2017, 00:00

  • The Role Of Companion Diagnostics In HTAS Of Drugs In France, Germany And The UK

    Oct 1, 2017, 00:00

  • Influenza-Related Attitudes of Healthcare Workers At Institutions for Acute and Chronic Diseases

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Alternative Measles-Mumps-Rubella Childhood Vaccination Schedules In Denmark

    Oct 1, 2017, 00:00

  • Rate of Hospitalization Due To Adverse Event and Length of Stay for Atezolizumab in Second and Third Line Metastatic Non-Small Lung Cancer (NSCLC) Using Phase 3 Oak Study

    Oct 1, 2017, 00:00

  • Systematic Review and Meta-Analysis of The Efficacy And Safety Of Amfepramone and Mazindol As A Monotherapy for The Treatment of Obese or Overweight Patients

    Oct 1, 2017, 00:00

  • Factors Associated with the Prevalence of Time in Front of Tv Between Brazilian Schoolers (2012 and 2015)

    Oct 1, 2017, 00:00

  • Management Of Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • Compliance And Treatment Satisfaction With Biological Treatments For Systemic Juvenile Idiopathic Arthritis (SJIA)

    Oct 1, 2017, 00:00

  • Case-Control Study on Risk Factors for Cancer from the Epidemiological Survey Carried Out on Beneficiaries of a Private Health Care Plan in Brazil- 10 Years of Follow-Up

    Oct 1, 2017, 00:00

  • Finding Undiagnosed Patients With Hepatitis C Virus- An Application Of State-Of-The-Art Machine Learning Methods

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns Among Patients Initiating on Statins in England

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Deep-Vein Thrombosis In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Impact of Comorbidities on The Risk And Cost of Hospitalization In Hiv-Infected Patients- Real World Data From The Abruzzo Region

    Oct 1, 2017, 00:00

  • Prediction Of Costs On Antiretroviral Therapy In The Republic Of Belarus

    Oct 1, 2017, 00:00

  • Ecocardiograma Sob Estresse Com Dobutamina- Alternativa Econômica E Exeqüível Na Avaliação De Risco Cardiovascular Pré Transplante Renal

    Oct 1, 2017, 00:00

  • Update on Impact of The Additional Benefit Extent of Orphan Drugs on Price Negotiations In The German Outpatient Sector

    Oct 1, 2017, 00:00

  • The Efficiency Path To Universal Health Coverage- Derivation Of Cost-Effectiveness Thresholds Based On Health Expenditures And Life Expectancy. Updated Country-Level Estimates For 194 Countries

    Oct 1, 2017, 00:00

  • PCN3 Pattern of Chemotherapy Related Adverse Effects Among Adult Cancer Patients Treated At Gondar University Referral Hospital, Ethiopia- A Cross Sectional Study

    Oct 1, 2017, 00:00

  • Hypertension Medication Access and Self-Management Among the Elderly by Education- Insights from the 2013 USA Medicare Current Beneficiary’s Survey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Additional Vaccination of Boys Against HPV In Germany

    Oct 1, 2017, 00:00

  • Assessing the Consistency in Reporting of Adverse Events Across Data Sources for Multiple Myeloma Treatment

    Oct 1, 2017, 00:00

  • Moving Pro Measures from the Promise to Impact in Oncology Clinical Practi Results from a Systematic Literature Review

    Oct 1, 2017, 00:00

  • Evaluation Of New Biologic Starts And Switching Among Real-World Rheumatoid Arthritis Patients In The United States

    Oct 1, 2017, 00:00

  • A Survey On The Society's Awareness Level On Aids In Turkey

    Oct 1, 2017, 00:00

  • Comparison Of Catheter-Related Complications Between Manually-Prepared Saline Flush Syringes And Commercially Available Pre-Filled Saline Flush Syringes

    Oct 1, 2017, 00:00

  • Inappropriate Prescribing of Antithrombotics Causes Poor Discharge Outcomes In Hospitalized Elderly Patients Using Stopp/Start Criteria 2015, A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • The Cost Of Prescribing Direct Oral Anticoagulants (DOACS) – There Is A Drug Cost But What Else?

    Oct 1, 2017, 00:00

  • Impact of Global Budget on Personal Medical Expense for Inpatient with Respiratory Disease- An Interrupted Time Series Analysis

    Oct 1, 2017, 00:00

  • Market Access Challenges To PD-1 Immunotherapies- Lessons From Nice

    Oct 1, 2017, 00:00

  • Accurate Representation Of Patients’ Opinions For Decision-Making- Are Online Health Communities Good Candidates?

    Oct 1, 2017, 00:00

  • Bibliometric Analysis of the Worldwide Research Productivity on Oral Health Related Quality of Life (Ohrql)

    Oct 1, 2017, 00:00

  • Understanding The Barriers To Vaccine Access And Uptake In EU5- Rotavirus Vaccination Case Study

    Oct 1, 2017, 00:00

  • Prevalence And Treatment Cost of Non-Communicable Diseases Related To Smoking In Indonesia

    Oct 1, 2017, 00:00

  • Early Modelling of The Cost-Effectiveness of Stratified Medicine In COPD

    Oct 1, 2017, 00:00

  • Effectiveness of a Pharmacist-Delivered Smoking Cessation Program in the State of Qatar- A Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Treatment Strategies and Outcomes In Patients Treated For Relapsed Refractory Multiple Myeloma Over 3 Years- Premiere Study

    Oct 1, 2017, 00:00

  • How Does The Scottish Medicines Consortium Assess The Value Of Orphan And Ultra-Orphan Drugs?

    Oct 1, 2017, 00:00

  • Patient Perception With Respect To The Overall Experience To A Patient-Friendly Equipment Design And The Impact Of Patient-Assisted Compression Feature During A Mammography Exam

    Oct 1, 2017, 00:00

  • Antiviral Medicines Assessment- What Is Driving High Clinical Added Value In France?

    Oct 1, 2017, 00:00

  • How Ireland's Colorectal Screening Programme Could Save More Lives, Save Money and Stay Within Existing Colonoscopy Capacity Limits- Evidence from the Miscan Microsimulation Model

    Oct 1, 2017, 00:00

  • Measuring The Intensity Of Care Coordination For Blood Cancer Patients In France

    Oct 1, 2017, 00:00

  • Spontaneous Abortion is Associated with an Increased Risk of Developing Psychiatric Diseases

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Ultrasound Screening, Cancer Patients, To Detect Asymptomatic Thrombosis

    Oct 1, 2017, 00:00

  • Well Thought Through But Badly Carried Out- An Evaluation Of The Reporting Quality Of Statutory Health Insurance Claims Data Analyses To Quantify The Target Population In Early Benefit Assessment In Germany

    Oct 1, 2017, 00:00

  • Assessing The Disease Course And Treatment of Psoriatic Arthritis (PSA) In Canada

    Oct 1, 2017, 00:00

  • Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Obeticholic Acid For The Treatment of Primary Biliary Cholangitis (PBC) Patients With Inadequate Response or Intolerance To Ursodeoxycholic Acid (UDCA) In France

    Oct 1, 2017, 00:00

  • Resultados Econômicos Da Gestão Clínica De Antimicrobianos Realizados Por Uma Operadora De Plano De Saúde Em Fortaleza-Brasil

    Oct 1, 2017, 00:00

  • Treatment with Biological Agents Among Patients with Ankylosing Spondylitis in Germany- A Claims Data Analysis

    Oct 1, 2017, 00:00

  • Custo Efetividade Do Uso Dos Inibidores De Protease No Tratamento Da Hepatite C Crônica- Comparação Entre O Uso Universal E O Uso Restrito Na Fibrose Avançada

    Oct 1, 2017, 00:00

  • Statin Induced Cataract In Cardiovascular Patients- A Retrospective Cohort Study of A Tertiary Healthcare Facility

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A 0.2 Μg/Day Fluocinolone Acetonide (FAC) Implant In The Treatment Chronic Diabetic Macular Oedema (DMO) In The UK

    Oct 1, 2017, 00:00

  • Wound Management In Diabetic Foot Ulcer (DFU) - Incremental Cost-Analysis Of Treating Diabetic Neuropathic Foot Lesions With Adjunct Hemoglobin Contact Spray In Germany

    Oct 1, 2017, 00:00

  • Comparing ITC Results From Lenvatinib Plus Everolimus For Second-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- Crossover Versus No Crossover

    Oct 1, 2017, 00:00

  • Notas Técnicas E Respostas Técnicas Rápidas- Seu Uso Nas Decisões Judiciais Em Saúde

    Oct 1, 2017, 00:00

  • The Economic Evaluation Of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis In Indonesia

    Oct 1, 2017, 00:00

  • Evaluating The Annual Cost Per Response Rate of Pirfenidone And Nintedanib For The Treatment of Patients With Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of ENTEREX® HPT, A Specialized Nutrition Supplement, for Patients with Liver Disease in Mexico

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Physicians' Guideline Adherence for Osteoporosis In Germany

    Oct 1, 2017, 00:00

  • Cost Burden Associated with Advanced Non-Small Cell Lung Cancer (A-NSCLC)- Impact of Disease Stage

    Oct 1, 2017, 00:00

  • Flexible-Dose Depot Buprenorphine Injection for Opioid Substitution Treatment In Heroin-Addicted Adults- A Swedish Pharmacoeconomic Perspective

    Oct 1, 2017, 00:00

  • Hospital Pharmacy Management Of Access To Direct-Acting Antivirals For The Treatment Of Hepatitis C And Its Contribution To Public Health And Economic Efficiency – A Single-Center Experience

    Oct 1, 2017, 00:00

  • How Beneficial Is Individual Patient Data In A Mixed Treatment Comparison?

    Oct 1, 2017, 00:00

  • Evaluación Económica De Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir En El Tratamiento De La Infección Crónica Por Hepatitis C En Uruguay

    Oct 1, 2017, 00:00

  • Chronic Non-Communicable Diseases (NCDS) and Body Mass Index (BMI) of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Survey Of Life Quality Among Patients With Insulin Dependant Diabetes Mellitus Managed By Insulin Pump

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Sequential Vaccination Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) And 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) On Adult Population In South Korea

    Oct 1, 2017, 00:00

  • Percepción De La Competencia En El Mercado De Medicamentos Esenciales Y Huérfanos En Panamá

    Oct 1, 2017, 00:00

  • Playing in the Same Pond - The Impact of Brexit on Clinical Trials and Access

    Oct 1, 2017, 00:00

  • Model Structure of Patient-Level Models for Schizophrenia- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Switching To Insulin Degludec (IDEG) In Real-World Clinical Practice In Italy

    Oct 1, 2017, 00:00

  • Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions

    Oct 1, 2017, 00:00

  • Custos Diretos De Eventos Adversos Identificados Em Um Hospital De Grande Porte No Brasil

    Oct 1, 2017, 00:00

  • What Stroke Image Do We Want? European Clinician Survey On Acute Stroke Imaging And Revascularisation Treatment

    Oct 1, 2017, 00:00

  • The Design of Economic Evaluation and Budget Impact Analysis Of Biosimilars- A Qualitative Study

    Oct 1, 2017, 00:00

  • Integrated 2 Screw Cepahlo-Medulary Device Reduces Device Related Post-Operative Complications and Pain After Intertrochanteric Fractures, Evidence From a Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery In The Management of Small Moderated-Sized Renal Stones

    Oct 1, 2017, 00:00

  • The Impact of Ageing on The Future Costs And Burden of Heart Failure In Portugal

    Oct 1, 2017, 00:00

  • Patient Preferences Regarding Treatment Options for Relapsed Refractory Multiple Myeloma (RRMM)

    Oct 1, 2017, 00:00

  • Influence Of Disease Familiarity On Implied Time Preferences For Seizure Frequency Reduction

    Oct 1, 2017, 00:00

  • Efficient Secondary Use of Representative Social and Health Care Data In Finland- Isaacus Data Lake, Analytics and Knowledge Management Pre-Production Project

    Oct 1, 2017, 00:00

  • Characteristics And Approvals Of Regulatory Submissions Based On Non-Randomized Studies In The United States And Europe

    Oct 1, 2017, 00:00

  • Comparison Of Utility Cost In Three Commercially Available Precision Medicine Approaches In Oncology

    Oct 1, 2017, 00:00

  • Testing The Beacon Tool With Health Economists And Clinicians – Is There Consistency In Its Application?

    Oct 1, 2017, 00:00

  • Using Regression Models To Accommodate Heterogeneity And Address Cohort Imbalance In Parametric Survival Models For Use In HTA

    Oct 1, 2017, 00:00

  • Comparison of Health Technology Assessments in Rheumatology from 2012 To 2016

    Oct 1, 2017, 00:00

  • Complementary and Alternative Medicine in the Management of Pain- A South African Community Survey

    Oct 1, 2017, 00:00

  • Assessing the Burden of Disease in Peripheral and Axial Spondyloarthritis in Mexico and Brazil

    Oct 1, 2017, 00:00

  • Efficacy and Safety of Topical Dapsone Gel 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Type

    Oct 1, 2017, 00:00

  • Caracterización Clínica Y Económica De Hospitalización Por Varicela En Niños En La Región Metropolitana Y Región De Valparaíso, Chile

    Oct 1, 2017, 00:00

  • Adult Risk Factors of Noncommunicable Disease Outcomes

    Oct 1, 2017, 00:00

  • Costs of Illness Progression for Different Multiple Sclerosis Phenotypes- A Population-Based Study in Sweden

    Oct 1, 2017, 00:00

  • Pipeline Assessment Of Βeta-Secretase Inhibitors For Alzheimer’s Disease- Hopes Or Gloom For A Trillion Dollar Market

    Oct 1, 2017, 00:00

  • Substitution Therapy With Flexible-Dose Depot Buprenorphine Injection To Treat Opioid Use Disorder In The United Kingdom- A Pharmacoeconomic Assessment

    Oct 1, 2017, 00:00

  • The Unknown Burden Of Celiac Disease In The US And Globally

    Oct 1, 2017, 00:00

  • Patient Burden of Rheumatoid Arthritis- Results of a Global Systematic Literature Review on Disability, Work Disruption, and Functional Capability in the Real World

    Oct 1, 2017, 00:00

  • Evaluation Framework for Digital Medicines in Europe

    Oct 1, 2017, 00:00

  • Patients’ Experiences Living With Chronic Hepatitis B Infection- A Multinational Qualitative Study

    Oct 1, 2017, 00:00

  • Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance®) In The Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) In Turkey Based Empa-Reg Outcome Data

    Oct 1, 2017, 00:00

  • Budget Impact Of Newly Approved Drugs By The Sicilian Drug Formulary Committee- An Introductive Analysis

    Oct 1, 2017, 00:00

  • Evaluating the Impact of PCSK9 Inhibitors on Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Ethical Considerations- Conducting Retrospective Non-Interventional Medical Record Review Studies in Europe

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis Comparing the Originator Recombinant Human Alfa to their Biosimilars Follitropin Alfa for the Treatment of Infertility

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Direct Meta-Analysis In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Second-Line Pharmacological Treatments of Acromegaly In Spain

    Oct 1, 2017, 00:00

  • Intercontinental Links Among Health Technology Assessment Organizations

    Oct 1, 2017, 00:00

  • A Systematic Review On Lifestyle Change Interventions Performed By Health Care Professionals Targeting Blood Pressure In Hypertensive Patients

    Oct 1, 2017, 00:00

  • Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy- A Systematic Review

    Oct 1, 2017, 00:00

  • Evaluación Económica De Medicamentos Para El Tratamiento De Síndrome Metabólico Desde La Perspectiva De Un Sistema De Salud Privado En Mexico

    Oct 1, 2017, 00:00

  • Comparison of Various Meta-Analysis Techniques

    Oct 1, 2017, 00:00

  • How Can Middle-Income Countries Get A Valid Estimate Of Cost-Effectiveness Of A Drug More Efficiently And Effectively?

    Oct 1, 2017, 00:00

  • The Impact of Disability on Activities of Daily Living, Productivity and Independency in Patients with Multiple Sclerosis- Findings from a 2016 Study in Europe and the United States

    Oct 1, 2017, 00:00

  • Atopic Dermatitis In Adults- Impact on Sexuality

    Oct 1, 2017, 00:00

  • Treatment Patterns And Lack of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Attainment Among High-Risk Patients Using High or Moderate Intensity Statin Therapy In Germany

    Oct 1, 2017, 00:00

  • Shouldn’t Nice Cost-Effectiveness Thresholds Be Changing With The Times?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of ACEI And ARBS II Drugs In Patients With Arterial Hypertension

    Oct 1, 2017, 00:00

  • Traditional and Complementary Medicine in Pregnancy and Postpartum- Reasons and Perceptions

    Oct 1, 2017, 00:00

  • Cost-Minimization Analysis of 10% Intravenous Immunoglobulin In Treatment Of Primary Immunodeficiencies In Children In The Russian Federation

    Oct 1, 2017, 00:00

  • Cost Efficiency Analysis of A New Arrhythmia Detection Algorithm In A Miniaturized Insertable Cardiac Monitor

    Oct 1, 2017, 00:00

  • The Effects Of The Economic Crisis On Health Status And Health Inequalities In Greece

    Oct 1, 2017, 00:00

  • Changes In Treatment Patterns Of Tyrosine Kinase Inhibitors Among Non-Small Cell Lung Cancer Patients Under The National Health Insurance In Taiwan

    Oct 1, 2017, 00:00

  • Cost of Nivolumab in Combination with Ipilimumab As First Line Treatment in Advanced Melanoma Across Various European Markets

    Oct 1, 2017, 00:00

  • Economic Analysis of Hepato Cellular Carcinoma Treatment by Severity of Disease

    Oct 1, 2017, 00:00

  • Conitec Reimbursement Decisions- Is There A Cost-Utility Decision Threshold?

    Oct 1, 2017, 00:00

  • Comparison of Weighting Methods Used During The Construction of Multiple-Criteria Decision Analysis Tool for Repeated Use In Lower Income Countries

    Oct 1, 2017, 00:00

  • Relaxing Rules For Pharmaceuticals And Benefit Coverage Expansion In Korea- The Impact On The Pharmaceutical Expenditure

    Oct 1, 2017, 00:00

  • Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Pharmaceutical Care Program For Systemic Arterial Hypertension Care Into Brazilian Public Heath System

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation- An Kazakhstan Perspective

    Oct 1, 2017, 00:00

  • The Application Of Big Data Analysis To Measure And Better Understand Medication Adheren A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Public Funding Of Cancer Treatment- Changes To The Process And Success Rate Over Time In Australia

    Oct 1, 2017, 00:00

  • Comparison Of Standard Parametric Survival Methods Versus More Flexible Approaches

    Oct 1, 2017, 00:00

  • Cost Effectivness Of Inteligent Liver Function Test(ILFT) For Investigating Patients With Abnormal Liver Function Test

    Oct 1, 2017, 00:00

  • Cost-Effectiveness in England of Cabozantinib for Patients with Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Eicosapentaenoic Acid (EPA) On Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Guideline Adherence In Docetaxel Treatment Of Castration Resistant Prostate Cancer (CRPC) Patients In A Real-World Population- The Castration Resistant Prostate Cancer Registry (CAPRI) In The Netherlands

    Oct 1, 2017, 00:00

  • Practical considerations for a dialysis provision model of care for end-stage renal disease (esrd). Benchmark of international experiences, opportunities for the mexican social security institute (imss)

    Oct 1, 2017, 00:00

  • Cost Drivers of Lung Cancer Care- Results From A Retrospective Chart Review of Pretreated Advanced Nsclc Patients in Europe

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden

    Oct 1, 2017, 00:00

  • Real World Data In France – State of The Art

    Oct 1, 2017, 00:00

  • Prospective Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, At One And Two Years Post Treatment, Through The Patient Assessment Of Chronic Illness Care Questionnaire

    Oct 1, 2017, 00:00

  • The Economic Burden Of Acute Bacterial Rhinosinusitis And Acute Otitis Media In Turkey- An Epidemiology Based Cost Of Illness Study With Respect To Clinical Practice And Available Guidelines

    Oct 1, 2017, 00:00

  • Contrasting Improving Rates of Cancer Survival In The Context of Life Years Lost Compared To The General Population

    Oct 1, 2017, 00:00

  • Price-Dose Relationship- The Case of Oral Oncology Drugs in Eu5

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Medication Review Interventions- A Review Of Literatures

    Oct 1, 2017, 00:00

  • Population Health Status Based On The EQ-5D-3L-Y Among Adolescents In Sweden - Results By Sex, Age And Socio-Economic Status

    Oct 1, 2017, 00:00

  • Modelling The Effectiveness of Ibrutinib Versus Physician’s Choice (PC) In Relapsed or Refractory (RR) Waldenström’s Macroglobulinemia (WM) Within England

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer in Portugal

    Oct 1, 2017, 00:00

  • A Retrospective Observational Survey of Buprenoprhine/Naloxone Use in France

    Oct 1, 2017, 00:00

  • Bevacizumab for Breast Cancer- Scientific Evidence Versus Real World Data (RWD) in Brazil

    Oct 1, 2017, 00:00

  • A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching To Paliperidone Palmitate 3-Monthly Formulation (PP3M) In The Public Sector of Hong Kong

    Oct 1, 2017, 00:00

  • Cost Comparison of Treatment Choices for Advanced Non-Small Cell Lung Cancer- An Observational Study

    Oct 1, 2017, 00:00

  • Are Generic Health State Utility Instruments Sufficiently Sensitive To Capture Changes In Health-Related Quality of Life In Patients With Visual Disorders?

    Oct 1, 2017, 00:00

  • Prognostic and Treatment Effect Modifying Baseline Factors for Visual Functioning Response in Non-Infectious Uveitis of the Posterior Segment Treated with Intravitreal Sirolimus

    Oct 1, 2017, 00:00

  • A Pilot Study About The Appropriateness Of The Breast Cancer Care Pathway In A Local Health Authority ASL CN2 (Piedmont, ALBA BRA-Italy) based on E.Pic.A. (Economic Appropriateness Of An Integrated Care Pathway) Protocol

    Oct 1, 2017, 00:00

  • Health State Utilities in Individuals with Goiter, Hypothyroidism, Hyperthyroidism and Graves’ Disease as an Example for Thyroid Disorders – A Systematic Review

    Oct 1, 2017, 00:00

  • Medication Use During Pregnancy in the Netherlands- A Population-Based Study

    Oct 1, 2017, 00:00

  • Smoking Cessation Interventions Based on Social Marketing Principles- A Review

    Oct 1, 2017, 00:00

  • Health Economic Cost Study For Senior Citizens In Ecuador

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treprostinil To Treatment of Patients With Pulmonary Arterial Hypertension Nyha Class Iv Without Response To Pharmacological Therapies In Mexico

    Oct 1, 2017, 00:00

  • Cost Saving Due To Self-Care Behavior Of Cardiovascular Patients

    Oct 1, 2017, 00:00

  • Economic Evaluation of A Patient Support Programme Abbvie Care 2.0 Immunology

    Oct 1, 2017, 00:00

  • Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

    Oct 1, 2017, 00:00

  • Secukinumab Significantly Reduces Work Impairment and Indirect Costs Compared To Ustekinumab and Etanercept In The United Kingdom

    Oct 1, 2017, 00:00

  • The Economic And Humanistic Burden of Patients on Treatment for Neovascular Age-Related Macular Degeneration

    Oct 1, 2017, 00:00

  • Open To The Public? A Comparative Analysis Of Data Published Under The “Ema Policy On The Publication Of Clinical Data” And Dossiers For Early Benefit Assessments In Germany

    Oct 1, 2017, 00:00

  • Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor

    Oct 1, 2017, 00:00

  • Occurrence or Remission of Antidiabetic Treatment Six Years after Bariatric Surgery- A Nationwide Matched Cohort Study

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Ulcerative Colitis- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Estimating The Reference Icer For Australia And Public Perceptions Toward Its Use

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective

    Oct 1, 2017, 00:00

  • Acne Vulgaris- Prevalence, Clinical forms and its Management in Pharmacy Students from Bahawalpur, Pakistan

    Oct 1, 2017, 00:00

  • Fatores Associados Aos Gastos com Imagenologia No Sistema Unico De Saude Brasileiro

    Oct 1, 2017, 00:00

  • Burden of Chronic Heart Failure on Caregivers- A Multinational Cross-Sectional Survey in Real World Setting

    Oct 1, 2017, 00:00

  • Electronic Capture of Clinical Outcome Assessment Data- Why is it Not Used More in Clinical Studies?

    Oct 1, 2017, 00:00

  • Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

    Oct 1, 2017, 00:00

  • Utility Meta-Regression; Frequentist Vs Bayesian Approaches in Multiple Myeloma

    Oct 1, 2017, 00:00

  • Hematopoietic Cell Transplantation Facilities- Geographic Access in Colombia

    Oct 1, 2017, 00:00

  • Relationship Between The Price Differences In Orphan Drugs With More Than One Benefit Assessment In Amnog And The Potential Influencing Factors

    Oct 1, 2017, 00:00

  • The Relationship Between Severity of Chronic Kidney Disease and Health Related Quality of Life Among a Nationally Representative Sample of Community Dwelling Adults in England

    Oct 1, 2017, 00:00

  • Instructions for Authors

    Oct 1, 2017, 00:00

  • The Resource Cost of Switching Stable Rheumatology Patients From An Originator Biologic To A Biosimilar In The UK

    Oct 1, 2017, 00:00

  • The Economic Impact of Caregiver For Patients With Atrial Fibrillation- An Italian Survey

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Differences in Distributional Properties and Responsiveness Between A Generic (EQ-5d) and Disease-Specific (ASUI) Utility Instrument in Patients with Severe Eosinophilic Asthma

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Primary HPV Screening With Dual-Stain Cytology Triage In The Cervical Cancer Screening Program Of Belgium

    Oct 1, 2017, 00:00

  • Trends In Fda Drug Promotion Enforcement Letters Over A Ten-Year Period

    Oct 1, 2017, 00:00

  • Assessment of Healthcare Costs of Infants In Exclusive Breastfeeding Versus Mixed or Artificial Breastfeed

    Oct 1, 2017, 00:00

  • Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab

    Oct 1, 2017, 00:00

  • Market Access Trends Across The EU5- 2009 To 2016- An Update

    Oct 1, 2017, 00:00

  • Leadership In Nursing

    Oct 1, 2017, 00:00

  • Changes In Private Financing Of The Greek Health System During The Economic Crisis

    Oct 1, 2017, 00:00

  • Acute Lymphoblastic Leukaemia’s Burden Of Disease In Portugal

    Oct 1, 2017, 00:00

  • Budget Impact of Post-Stroke Dysphagia- Database Analyses of Hospital Discharges In France And Switzerland

    Oct 1, 2017, 00:00

  • Pharmacology for Peripheral Arterial Disease in the Netherlands; Patient Journey and Platelet Aggregation Inhibitor Prescription

    Oct 1, 2017, 00:00

  • Evolución De La Calidad De Atención En Personas Con Diabetes Tipo 2 (DMT2) De Argentina- Resultados Del International Diabetes Management Practices Study (IDMPS)

    Oct 1, 2017, 00:00

  • Hydrogen Peroxide As A Sustainable Alternative for Sterilization

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes In Labels And Package Leaflets Of Drugs Approved By The European Medicines Agency From 2007 To 2017

    Oct 1, 2017, 00:00

  • Using Outcome Data to Inform Healthcare Professional – Patient Discussion- A Database of Treatment Effects

    Oct 1, 2017, 00:00

  • The Incidence Of Liver Complications In Israel

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Abobotulinumtoxin A For Hemiparesis In Adults With Upper Limb Spasticity After Stroke or Traumatic Brain Injury In The United Kingdom – A Bayesian Analysis

    Oct 1, 2017, 00:00

  • A Longitudinal Pattern of Care for Prostaglandin Prescription for Glaucoma In Korea

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- An Application Of Value Based Pricing Using Discrete Choice Experiment Methods

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- Where The Functional Health Deterioration and The High Economic Impact Are Inseparable. Challenges In A Latin American Country

    Oct 1, 2017, 00:00

  • Damned if You ‘D’? Evidence the Selection of the Appraisal Committee May Affect Nice Technology Assessmet Outcomes

    Oct 1, 2017, 00:00

  • Comorbidity Indices Based On Health-Related Quality Of Life Are More Strongly Associated With Patient Outcomes Than Mortality-Based Indices

    Oct 1, 2017, 00:00

  • real-World Data (RWD) On The Attainment Of Composite Quality Measures (Cqm) In A Brazilian Population With Self-Reported Type-2 Diabetes Mellitus (T2DM)

    Oct 1, 2017, 00:00

  • Economic Evaluation of Dialysis Dependence Following Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients

    Oct 1, 2017, 00:00

  • Assessing The Joint Probability Of Cost-Effectiveness And Affordability In Decision Making

    Oct 1, 2017, 00:00

  • Limitaciones De Las Evaluaciones Económicas En Salud En La Asignación De Recursos Para Medicamentos Para Enfermedades Raras- Un Scoping Review

    Oct 1, 2017, 00:00

  • Patient and Caregiver Burden in Congenital Adrenal Hyperplasia (CAH) in Children- Results of a Structured Literature Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Chidamide Versus Chemotherapy on The Treatment of Peripheral T - Cell Lymphoma Patients In China

    Oct 1, 2017, 00:00

  • Effect of Anti-Diabetic Drugs On Risk of Fracture In Type 2 Diabetes Mellitus Patients- A Network Meta-Analytic Synthesis of Randomized Controlled Trials of Thiazolidinediones

    Oct 1, 2017, 00:00

  • Development And Utility Valuation Of Health States For Haemophilia And Related Complications In Europe And In The USA

    Oct 1, 2017, 00:00

  • Economic Burden of Burn Injuries Treated With An Enzymatic Debriding Agent In Spain

    Oct 1, 2017, 00:00

  • Characterisitcs of Patients Receiving Leflunomide, Methotrexate or Leflunomide Plus Methotrexate for the Treatment of Rheumatoid Arthritis in a Real-Life Setting in Colombia

    Oct 1, 2017, 00:00

  • Probabilistic Cost-Utility Analysis of Pergoveris in Women Patients Undergoing IVF

    Oct 1, 2017, 00:00

  • The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

    Oct 1, 2017, 00:00

  • Effects Of Availability Of Essential Medicines List On Sellected Domains Of Pharmacy Services In A National Health Insurance Scheme (NHIS) Accredited Pharmacy Of A University Teaching Hospital In Nigeria; An Intervention Study

    Oct 1, 2017, 00:00

  • Patterns of Biological Therapy Use in Patients with Rheumatoid Artrhitis in a Real-Life Setting in Colombia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • Costo De Eventos Coronarios Agudos En Población Con Factores De Riesgo Cardiovascular- Análisis Retrospectivo

    Oct 1, 2017, 00:00

  • Use of New Therapies and Hospital Admission Near the End of Life in Castration Resistant Prostate Cancer (CRPC) in the Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

    Oct 1, 2017, 00:00

  • Granulocyte-Colony Stimulating Factor (G-CSF)- Potential Financial Savings For German Hospitals

    Oct 1, 2017, 00:00

  • Evaluation of Pharmacist’s Educational and Counseling Impact on Patients Clinical Outcomes in a Diabetic Setting

    Oct 1, 2017, 00:00

  • Determining The Shares of The Cost of Anesthesia And Intensive Care Medicine In Stationary And Stationary Part And Their Development Since 2006 In Germany

    Oct 1, 2017, 00:00

  • Cost Effectiveness Evaluation of Transradial Versus Transfemoral Access For Emergent Percutaneous Coronary Intervention In Patients With St Elevation Myocardial Infarction

    Oct 1, 2017, 00:00

  • Revisão Sistemática Das Diretrizes De Análise De Impacto Orçamentário

    Oct 1, 2017, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Different Agonists of The Thrombopoietin Receptor In Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura In Actual Practice In Russia

    Oct 1, 2017, 00:00

  • One Size Does Not Fit All- What Are The Appropriate Screening Intervals For People At Risk Of Diabetic Retinopathy

    Oct 1, 2017, 00:00

  • Societal Cost Patterns By Spine Surgical Outcome Groups And Patients Treated With Spinal Cord Stimulation Following Spine Surgery

    Oct 1, 2017, 00:00

  • Outcome Measures used to Assess Interventions for Asthma Control- A Systematic Review

    Oct 1, 2017, 00:00

  • Health Technology Assessment To Improve Patient Care Through Pharmaceutical Care- Clinical Pharmacist’s Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Additional Human Papillomavirus Vaccination Programmes, in The Netherlands

    Oct 1, 2017, 00:00

  • Adhrence To Routine Medical Screening Among Healthcare Professionals

    Oct 1, 2017, 00:00

  • The Multi-Criteria Decision Analysis in the Priority Setting of Emerging Medicines

    Oct 1, 2017, 00:00

  • Structural Change In The Hungarian Health Care System

    Oct 1, 2017, 00:00

  • Risk of Acute Exacerbation and Severe Acute Exacerbation Associated With Different Severities of Copd At Diagnosis- A Prospective Cohort Study in Korea

    Oct 1, 2017, 00:00

  • Measuring Changes In Patterns of Tobacco Product Use Over Time- Transition Probability Approaches

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis of Artificial Urinary Sphincter Versus Advance Male Sling In Post Prostatectomy Stress Urinary Incontinen A Canadian Healthcare Perspective

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67 (current)
  • 68
  • 69
  • 70
  • »